Takeda Promotes Christopher Weber to CEOBy
Takeda Pharmaceutical Company Limited’s Board of Directors have named Christophe Weber, now representative director, president and chief operating officer (COO), to representative director, president and chief executive officer (CEO), effective April 1, 2015. Yasuchika Hasegawa, now representative director, chairman of the board, and CEO, will assume the position of representative director, chairman of the board.
The appointment is the result of a decision-making process endorsed by Takeda’s Nomination Committee, which serves as an advisory body to the board of directors. It has been also decided that the position of COO will no longer exist, effective April 1, 2015.
Source: Takeda Pharmaceutical